Optave Diagnostics, a technology company developing an endoscopic probe device that uses photoacoustic imaging (PAI) to aid in cancer detection and diagnosis, today announced it has been awarded a $256,000 Small Business Innovation Research (SBIR) Phase I grant from the National Science Foundation (NSF).
Early Charm Ventures, a company that creates, owns and operates ventures that convert science to revenue, today welcomed Rashi Sultania – a chemical and biomolecular engineer – as Research Associate focusing on R&D and product development for Early Charm’s advanced materials and drug design portfolio of companies.
Early Charm Ventures, a company that creates, owns and operates ventures that convert science to revenue, today announced the hiring of Anthony Benter – an experienced business administrator with skills in sales, personnel management and accounting – as Executive Assistant.
Early Charm Ventures, a company that creates, owns and operates ventures that convert science to revenue, today welcomed Michael LaScola – a chemical and bioengineer – as Research Associate with Early Charm’s Materic.
Early Charm Ventures, a company that creates, owns and operates ventures that convert science to revenue, today welcomed Jacob Isbell – an electrical and computer engineer – as Scientist for Machine Vision focusing on product development for Early Charm’s machine vision portfolio of companies.
Early Charm Ventures, a company that creates, owns and operates ventures that convert science to revenue, today welcomed Nathan Nimbargi – a mechanical engineer with significant sales and customer service experience – as Technical Sales Specialist with Early Charm’s Materic.
This position with Early Charm portfolio company SilcsBio manages customer service projects as well as support technical software sales. SilcsBio scientists enable drug discovery scientists to discover new drug candidates, optimize lead compound candidates, and facilitate the formulation of protein-based drugs using a patented physics- and structure-based approach.
This Early Charm role will place you on the cutting edge of moving new science toward market by working to discover unmet market needs, understand how new science can impact those needs and analyze opportunities for us to license patents from universities and government labs.
SilcsBio, an Early Charm drug design portfolio company, today announced the launch of a partnership with Helix BioStructures to tap mutual areas of expertise in drug design and spur new opportunities for pharmaceutical and research organizations.
Early Charm is a venture studio that converts science to business. We specialize in turning brilliant scientific discoveries into companies focused on growth. We don’t chase quick exits. We grow companies that create sustainable value.
Copyright © 2008 – 2022 Early Charm Ventures